Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_assertion type Assertion NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_head.
- NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_assertion description "[In the GAgP group, BOP (%) was significantly higher in patients with the 298Asp allele (Asp+) compared to patients without the Asp allele (Asp-) (P = 0.015).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_provenance.
- NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_assertion evidence source_evidence_literature NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_provenance.
- NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_assertion SIO_000772 16881803 NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_provenance.
- NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_assertion wasDerivedFrom befree-20140225 NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_provenance.
- NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_assertion wasGeneratedBy ECO_0000203 NP621180.RA5DxusX5cJqCZqntO5QJM6cxPPEbbpevpugMhnhEjyUQ130_provenance.